The chemokine CCL21 protects normal marrow progenitors from ara-C cytotoxicity

Cancer Chemotherapy and Pharmacology

Volumn 50, Issue 2, 2002, Pages 163-166

  Hromas, Robert ^a   Cooper, Scott ^a   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Ara C; Chemokine; Leukemia; Myeloid progenitors; Myelosuppression

Indexed keywords

CHEMOKINE; CYTARABINE; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ANIMAL CELL; ARTICLE; BIOASSAY; BONE MARROW; BONE MARROW SUPPRESSION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; BONE MARROW DISEASES; CELL DIVISION; CHEMOKINES, CC; COLONY-FORMING UNITS ASSAY; CYTARABINE; DRUG EVALUATION, PRECLINICAL; HEMATOPOIETIC STEM CELLS; MICE; S PHASE;

EID: 0036351301     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-002-0486-7     Document Type: Article

References (21)

1. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
2. CC chemokines in allergic inflammation
3. Chemokines and hematopoiesis
4. Suppressive effects of the chemokine (Macrophage Inflammatory Protein) family of cytokines on normal and leukemia myeloid cell proliferation
5. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression
6. Human chemokines: Enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice
7. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer
8. Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors
9. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
10. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo
11. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
12. Chemokines and tissue injury
13. Expression of the chemokine superfamily in rheumatoid arthritis
14. Cloning and characterization of Exodus, a novel beta-chemokine
15. Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension
16. The Exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors
17. Role of early reperfusion in the induction of adhesion molecules and cytokines in previously ischemic myocardium
18. The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage
19. Regulation of human natural killer cell migration and proliferation by the Exodus subfamily of CC chemokines
20. Novel lymphocyte-specific CC chemokines and their receptors
21. Recent advances in chemokines and chemokine receptors